A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor
Clinical trial NCT05262491 · RECRUITING
Trial details
- NCT number
- NCT05262491
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-14
- Primary completion
- 2026-12-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.